NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

The Cooper Companies, Inc. (COO) Stock Analysis

The Cooper Companies, Inc. (COO) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

COO

$58.97

−$0.15 (−0.25%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare COO with… →

COO Key Statistics

As of Oct 21, 2026
Trading
Open
$58.67
Previous Close
$59.12
Day's Range
58.43–59.38
52-Week Range
51.01–89.83
Volume
2.15M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.83
Valuation
Market Cap
$11.21B
P/E Ratio
20.26
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
12.57
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.56
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.65
EPS (ttm)Profit attributable to each share over the last twelve months.
2.91
Financials (FY)
Revenue (FY)
$4.09B+5.06%
Net Income (FY)
$374.90M−4.44%
Profit marginThe share of revenue left as profit after all costs and taxes.
13.46%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
190.16M
1-Year Return
−21.37%
Dividend and dates
Avg Volume
3.31M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, COO closed at $58.97, −21.37% over 1 year.

The Cooper Companies, Inc. (COO) has a market capitalization of $11.21B.

In fiscal 2025, COO reported revenue of $4.09B.

COO Stock Return by Calendar Year

The Cooper Companies, Inc. (COO) 10-year return: what $10,000 became

1 year
$10,000 $7,863
−21.37%
5 years
$10,000 $5,733
−42.67%
10 years
$10,000 $13,212
+32.12%

If you had invested $10,000 in The Cooper Companies, Inc. (COO) 10 years ago, at the close on October 21, 2016, it would have been worth $13,212 at the close on October 21, 2026: +32.12% in total, +2.82% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−28.05%
2025−10.85%
2024−2.83%
2023+14.47%
2022−21.06%
2021+15.33%
2020+13.10%
2019+26.27%
2018+16.84%
2017+24.59%
2016 (partial year)−3.51%

As of October 21, 2026.

COO Revenue and Earnings by Fiscal Year

FY ends October
Fiscal yearRevenueNet incomeNet margin
2025$4.09B$374.90M9.2%
2024$3.90B$392.30M10.1%
2023$3.59B$294.20M8.2%
2022$3.31B$385.80M11.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$4.09B$2.68B$682.90M$374.90M9.2%
2024$3.90B$2.60B$705.70M$392.30M10.1%
2023$3.59B$2.36B$533.10M$294.20M8.2%
2022$3.31B$2.14B$507.60M$385.80M11.7%

Annual figures as reported, in the company's reporting currency. As of October 31, 2025.

COO Dividend History

$0.02+0.0% vs 2022

Dividends per share, 2023 · 2 payments

YearDividends per sharePaymentsChange
2023$0.022+0.0%
2022$0.022+0.0%
2021$0.022+0.0%
2020$0.022+0.0%
YearDividends per sharePaymentsChange
2023$0.022+0.0%
2022$0.022+0.0%
2021$0.022+0.0%
2020$0.022+0.0%
2019$0.022+0.0%
2018$0.022+0.0%
2017$0.022—

Most recent payment: $0.01 per share, ex-dividend July 26, 2023. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

COO Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricCOOMedical Instruments & Supplies medianvs median
P/E20.2631.1935% below
P/S ratio2.652.602% above
Profit margin13.46%1.62%11.8 pts above

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The Cooper Companies, Inc. (COO) carries a market capitalisation of $11.21B. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. Headcount on file is 15,000.

Over the past 52 weeks the price has ranged from $51.01 to $89.83. The most recent close on file for COO is $58.97, dated October 21, 2026. That is −$0.15 (−0.25%) against the previous close. The latest close sits 15.6% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $4.09B. That is +5.06% against the prior fiscal year, when revenue was $3.90B. Net income for the same year was $374.90M. That is −4.44% against the prior fiscal year. Profit margin runs at 13.46%. That is 11.8 percentage points above the Medical Instruments & Supplies median of 1.62%. Trailing earnings per share are 2.91.

Across the 4 fiscal years on file, revenue moves from $3.31B in 2022 to $4.09B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 20.26 times earnings. That is 35.04% below the Medical Instruments & Supplies median of 31.19. On forward earnings the ratio is 12.57. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.56. The price-to-sales ratio is 2.65. On price-to-sales that is 1.88% above the Medical Instruments & Supplies median of 2.6. 50 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

The reported beta is 0.83. Annualized volatility over the trailing 10 years is 28.61%. The trailing one-year total return is −21.37%. Measured over 10 years, that is +2.82% a year compounded.

Growth & Income

The dividend record for COO runs through 2023. Dividends are recorded for 7 calendar years; 2023 shows 2 payments totalling $0.02 a share. The year before, 2022, totalled $0.02 a share.

The strongest complete calendar year on file is 2019 at +26.27%; the weakest is 2022 at −21.06%. Of the 9 complete calendar years on file, 6 finished higher. 2026 is still running; the total return is −28.05% year to date.

Peer Comparison

The Cooper Companies, Inc. (COO) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
The Cooper Companies, Inc. COO $11.21B 20.3
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. The Cooper Companies, Inc. trades at a P/E of 20.3.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About The Cooper Companies, Inc.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Visit website →